Human Medicines European Public Assessment Report (EPAR): Twinrix Paediatric, Hepatitis-A (Inactivated) and Hepatitis-B (rDNA) (HAB) Vaccine (Adsorbed), Immunization,Hepatitis B,Hepatitis A, Date of Authorisation: 10/02/1997, Revision: 20, Status: Authorised

Case Medical Research
doi 10.31525/cmr-962c24
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Entecavir Mylan, Entecavir, Hepatitis B, Date of Authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Rebetol, Ribavirin, Hepatitis C, Chronic, Date of Authorisation: 06/05/1999, Revision: 32, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Trumenba, Meningococcal Group B Vaccine (Recombinant, Adsorbed), Meningitis, Meningococcal, Date of Authorisation: 24/05/2017, Revision: 4, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Mixtard, Insulin Human (rDNA), Diabetes Mellitus, Date of Authorisation: 07/10/2002, Revision: 18, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Colobreathe, Colistimethate Sodium, Cystic Fibrosis, Date of Authorisation: 13/02/2012, Revision: 10, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Instanyl, Fentanyl, Pain,Cancer, Date of Authorisation: 20/07/2009, Revision: 21, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Cervarix, Human Papillomavirus Vaccine [Types 16, 18] (Recombinant, Adjuvanted, Adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Immunization, Date of Authorisation: 20/09/2007, Revision: 32, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Revinty Ellipta, Fluticasone Furoate / Vilanterol, Asthma, Date of Authorisation: 02/05/2014, Revision: 16, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Vepacel, Prepandemic Influenza Vaccine (H5N1) (Whole Virion, Inactivated,prepared in Cell Culture), Influenza, Human,Immunization,Disease Outbreaks, Date of Authorisation: 17/02/2012, Revision: 9, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy